<?xml version="1.0" encoding="UTF-8"?>
<ref id="pone.0191797.ref034">
 <label>34</label>
 <mixed-citation publication-type="journal">
  <name>
   <surname>Droppa-Almeida</surname>
   <given-names>D</given-names>
  </name>, 
  <name>
   <surname>Vivas</surname>
   <given-names>WLP</given-names>
  </name>, 
  <name>
   <surname>Kelly</surname>
   <given-names>K</given-names>
  </name>, 
  <name>
   <surname>Silva</surname>
   <given-names>O</given-names>
  </name>, 
  <name>
   <surname>Rezende</surname>
   <given-names>AFS</given-names>
  </name>, 
  <name>
   <surname>Simionatto</surname>
   <given-names>S</given-names>
  </name>, 
  <etal>et al</etal>
  <article-title>Recombinant CP40 from 
   <italic>Corynebacterium pseudotuberculosis</italic> confers protection in mice after challenge with a virulent strain
  </article-title>. 
  <source>Vaccine</source>. 
  <year>2016</year>;
  <volume>34</volume>: 
  <fpage>1091</fpage>â€“
  <lpage>1096</lpage>. 
  <comment>doi: 
   <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.vaccine.2015.12.064" xmlns:xlink="http://www.w3.org/1999/xlink">10.1016/j.vaccine.2015.12.064</ext-link>
  </comment>
  <?supplied-pmid 26796140?>
  <pub-id pub-id-type="pmid">26796140</pub-id>
 </mixed-citation>
</ref>
